Effects of Pinus pinaster and Pinus koraiensis seed oil supplementation onlipoprotein metabolism in the rat

Citation
G. Asset et al., Effects of Pinus pinaster and Pinus koraiensis seed oil supplementation onlipoprotein metabolism in the rat, LIPIDS, 34(1), 1999, pp. 39-44
Citations number
34
Categorie Soggetti
Agricultural Chemistry","Biochemistry & Biophysics
Journal title
LIPIDS
ISSN journal
00244201 → ACNP
Volume
34
Issue
1
Year of publication
1999
Pages
39 - 44
Database
ISI
SICI code
0024-4201(199901)34:1<39:EOPPAP>2.0.ZU;2-H
Abstract
The aim of the present study was to assess the effect of vegetal oils obtai ned from Pinus pinaster and P. koraiensis seeds on plasma lipoprotein level s and apolipoprotein (apo) gene expression in rats. These oils contain two particular fatty acids of the Delta 5-unsaturated polymethylene-interrupted fatty acid (Delta 5-UPIFA) family: all-cis-5,9,12-18:3 (pinolenic) and/or all-cis-5,11,14-20:3 (sciadonic) acids. Rats were fed for 28 d a diet conta ining 5% (w/w) oil supplement. Two control diets were prepared to match the fatty acid composition of P. pinaster or P. koraiensis oils with the excep tion of Delta 5-UPIFA, which were replaced by oleic acid. Pinus pinaster se ed oil decreased serum triglycerides by 30% (P< 0.02), very low density lip oprotein (VLDL)-triglycerides by 40% (P < 0.01), and VLDL-cholesterol by 33 % (P < 0.03). Pinus koraiensis seed oil decreased serum triglycerides by 16 % [not statistically significant (ns)] and VLDL-triglycerides by 21% (ns). Gel permeation chromatography and nondenaturating polyacrylamide gel electr ophoresis showed a tendency of high density lipoprotein to shift toward lar ger particles in pine seed oil-supplemented rats. Finally, P. pinaster seed oil treatment was associated with a small decrease of liver apoC-III (P< 0 .02) but not in apoE, apoA-I, or apoA-II mRNA levels. The levels of circula ting apo were not affected by pine seed oil supplementation. In conclusion, P. pinaster seed oil has a triglyceride-lowering effect in rats, an effect that is due to a reduction in circulating VLDL.